U.S. Markets open in 9 hrs 15 mins
  • S&P Futures

    4,411.75
    +22.25 (+0.51%)
     
  • Dow Futures

    34,984.00
    +152.00 (+0.44%)
     
  • Nasdaq Futures

    15,026.50
    +70.75 (+0.47%)
     
  • Russell 2000 Futures

    2,239.80
    +18.20 (+0.82%)
     
  • Crude Oil

    73.16
    -0.79 (-1.07%)
     
  • Gold

    1,814.80
    -2.40 (-0.13%)
     
  • Silver

    25.54
    -0.01 (-0.03%)
     
  • EUR/USD

    1.1875
    0.0000 (-0.0000%)
     
  • 10-Yr Bond

    1.2390
    -0.0300 (-2.36%)
     
  • Vix

    18.24
    +0.54 (+3.05%)
     
  • GBP/USD

    1.3901
    -0.0005 (-0.0361%)
     
  • USD/JPY

    109.6680
    +0.0530 (+0.0484%)
     
  • BTC-USD

    39,711.47
    -2,677.61 (-6.32%)
     
  • CMC Crypto 200

    960.90
    +11.00 (+1.16%)
     
  • FTSE 100

    7,032.30
    -46.12 (-0.65%)
     
  • Nikkei 225

    27,799.10
    +515.51 (+1.89%)
     

Masimo's Wearable Thermometer Scores FDA Approval For Prescription, OTC Use

·1 min read
  • Masimo (NASDAQ: MASI) has announced that Radius Tº, a wearable, wireless thermometer, has received FDA 510(k) clearance for both prescription and over-the-counter (OTC) use on patients and consumers five years and older.

  • With continuous temperature measurements and Bluetooth connectivity, Radius Tº automates remote, ongoing body temperature status for clinicians through its paired connection to a Masimo patient monitoring or telehealth solution and for consumers through the Masimo Radius Tº smartphone application.

  • For prescription use, Radius Tº is compatible with both the Root Patient Monitoring and Connectivity Hub and the Rad-97 patient monitor for use in the hospital, as part of the Masimo Hospital Automation platform.

  • Price Action: MASI shares are down 1.27% at $237 during the market session on the last check Monday.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.